Molecular Targeting Technologies (MTTI) and Brookline Capital Markets are collaborating at the 2nd Targeted Radionuclide Pharmaceuticals (TRPs) Supply Chain...

Genethon, a leading gene therapy research facility, has significantly progressed in developing a new generation of adeno-associated virus (AAV)...

GI Partners has acquired a majority stake in eClinical Solutions, a leading provider of digital clinical software and services,...

Results from the Phase 3 PURPOSE 2 clinical trial have confirmed the effectiveness of Lenacapavir, an injectable HIV-1 capsid...

EMD Serono presented data at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) conference, showcasing the...

Sanofi, RadioMedix, and Orano Med have partnered to advance AlphaMedixTM, a treatment for a rare cancer known as neuroendocrine...

The 2024 Veeva R&D and Quality Summit brought together industry leaders and professionals to discuss the latest clinical trial...

The biomedical field is witnessing a groundbreaking era with the advent of tetraspecific antibodies. These antibodies, representing the next...

Gilead Sciences and Genesis Therapeutics have formed a collaboration to develop novel therapies through generative AI technology. Genesis’ GEMS...

AiCure, a pioneer in clinical trial monitoring and patient engagement, will debut its innovative H.Code platform at the DPHARM...